Three paid tiers. Source-backed value.
Free public search. Pro for individual analysts. Analyst Desk for pipeline, patents, sponsor financial relationships, and wire-feed intelligence. Research Team for multi-seat desks that need global pharmacovigilance and ex-U.S. market-access coverage. Subscribe any time. Cancel any time.
Search public registries. See live trial movement, FDA safety alerts, and openFDA recalls.
- ✓Search ClinicalTrials.gov (top 5)
- ✓Live FDA MedWatch alerts
- ✓Latest openFDA recalls
- ·No watchlist alerts
- ·No exports
- ·No AI brief
For analysts, consultants, journalists, and serious independent researchers. Full watchlists. Daily refresh. Source-backed AI briefs.
- ✓Unlimited watchlists
- ✓Daily source refresh
- ✓Trial status change alerts
- ✓Safety signal cards (FDA Drug Safety Communications, openFDA recalls, DailyMed, Open Targets PV)
- ✓Drugs@FDA approval & CRL tracking
- ✓FDA Drug Shortage monitoring
- ✓PubMed literature watch
- ✓AI-generated daily brief
- ✓Exportable briefs (PDF + CSV)
- ✓Source-anchored Evidence Room
- ✓1 seat
Subscription auto-renews monthly at $199 until cancelled. Cancel any time. Agree to Terms.
For biotech investors, equity analysts, BD teams, and competitive-intelligence groups. Adds patents, pipeline funding, KOL mapping, sponsor wires, and SEC disclosure monitoring.
- ✓Everything in Pro
- ✓USPTO PatentsView — patent-cliff & IP-portfolio mapping
- ✓NIH RePORTER — pre-trial pipeline visibility
- ✓CMS Open Payments — KOL & investigator due diligence
- ✓Newswire feeds (PR Newswire / GlobeNewswire / Business Wire)
- ✓SEC EDGAR disclosure monitoring (8-K / 10-K / 10-Q)
- ✓Sponsor comparison dashboards
- ✓1 seat
Subscription auto-renews monthly at $399 until cancelled. Cancel any time. Agree to Terms.
For research desks, biotech consultancies, global pharma teams, and investor groups. Adds global pharmacovigilance and ex-U.S. market-access decisions. 5 seats included.
- ✓Everything in Analyst Desk
- ✓5 seats included (additional seats $39/seat/mo)
- ✓WHO VigiAccess — global pharmacovigilance
- ✓NICE (UK) — health-technology appraisals
- ✓PMDA (Japan) — approvals and safety reviews
- ✓Disease-area dashboards
- ✓Custom watchlist AI briefs
- ✓Priority support
Subscription auto-renews monthly at $699 until cancelled. Additional seats $39/seat/mo. Agree to Terms.
Every signal is source-backed
Source · source URL · source published timestamp · ingested timestamp · previous value · new value · normalized signal · AI-assisted interpretation · caveat. Export PDF or CSV for any record. This is the same evidence that backs every card you see across Clinical Trial Signal.